Tirzepatide

OVERVIEW

A modified peptide that activates both GIP and GLP-1 receptors. It is one of the best-characterized incretin-based compounds in modern metabolic research.

RESEARCH FOCUS

Incretin signaling, appetite and satiety biology, glucose-dependent insulin signaling, energy balance, and body-composition research.

CLASS / TYPE

Dual GIP / GLP-1 receptor agonist

KEY PATHWAYS / TARGETS

GIP receptor (GIPR) and GLP-1 receptor (GLP-1R)

RESEARCH STATUS

FDA-approved medicine in the United States for specific indications; this page is informational and does not provide treatment guidance.

COMMON RESEARCH AREAS

Metabolic signaling • endocrinology • appetite biology • glucose regulation • cardiometabolic research

RESEARCH NOTE

Tirzepatide has extensive clinical and pharmacology literature. Its defining scientific feature is simultaneous activity at two incretin receptors.